New York's Medical Cannabis Companies Seek A Less Pricey Route To Go Recreational

Zinger Key Points
  • Columbia Care exec Ngiste Abebe told the Times: 'I would love to see the economic analysis that justifies $20 million.'
  • Ascend Wellness recently ditched plans to buy the New York operations of MedMen NY Inc.

Medical cannabis operators in New York are worried about having to pay an exorbitant fee in order to go recreational.

According to the New York Times, in order to sell marijuana outside of a medical program, multi-state operators (MSOs) must pay a fee of $20 million.

Winning bidders of the state's first 10 cannabis licenses, once happy at the thought of entering a new market, now feel slighted (the large fee is meant to help those who had been harmed or affected by the federal government's so-called War on Drugs).

“It needs to be grounded in the economic realities of the market," Ngiste Abebe, president of the New York Medical Cannabis Industry Association, told the Times.

Abebe, who is an executive at Columbia Care, added that while operators were “excited” to support social equity, she “would love to see the economic analysis that justifies $20 million.”

So far, companies are already spooked about doing business in the Empire State. The Times pointed out how Ascend Wellness Holdings AAWH AAWH, for example, recently ditched plans to buy the New York operations of MedMen NY Inc. MMNFF.

Chris Alexander, the executive director of the state’s Office of Cannabis Management, said that while regulators were “sensitive” to registered operators’ perspectives, the fee is meant to support New York's social equity program.

“So that’s kind of the guiding factor,” Alexander said.

Operators are now urging regulators to lessen the fee to approximately $3 million per company, and allow them to pay it over time rather than up front. The fee would need to be approved by the state Cannabis Control Board.

Photo: Courtesy Of Pixabay

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisPenny StocksSmall CapMarketsAscend Wellness HoldingsChris AlexanderColumbia CareGov. Kathy Hochulmedical marijuanaMedMen NY Inc.MM Enterprises USA LLCNew York Medical Cannabis Industry AssociationNgiste AbebeNY Office of Cannabis ManagementRecreational Marijuana
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on – Prices will increase very soon!